Bank Of Nova Scotia
Source: SEC Form 13F · as of Mar 2026Bank Of Nova Scotia holds 15 biotech & pharma companies tracked by BioSniper, totaling $232.4M in value as of Mar 2026 (SEC Form 13F).
Companies held
15
Total value held
$232.4M
BioSniper AIPage evidence connected
Prepared research question
What matters most for GILEAD SCIENCES, INC. (GILD)—catalysts, financial risk and supporting evidence?
Run cited research
Traceable citations · Unknowns marked
| Company | Shares | Value |
|---|---|---|
| GILDGILEAD SCIENCES, INC. | 723,376 | $100.8M |
| REGNREGENERON PHARMACEUTICALS, INC. | 97,520 | $75.3M |
| ROIVRoivant Sciences Ltd. | 1,310,387 | $36.3M |
| ARWRARROWHEAD PHARMACEUTICALS, INC. | 135,960 | $8.5M |
| INCYIncyte Corp. | 27,500 | $2.6M |
| ALNYALNYLAM PHARMACEUTICALS, INC. | 7,798 | $2.6M |
| INSMINSMED Inc | 15,203 | $2.5M |
| ANTXAN2 Therapeutics, Inc. | 459,194 | $1.6M |
| RVMDREVOLUTION MEDICINES, INC. | 10,305 | $1.0M |
| MRNAModerna, Inc. | 7,783 | $395K |
| RLMDRELMADA THERAPEUTICS, INC. | 30,600 | $213K |
| ALXOALX ONCOLOGY HOLDINGS INC | 105,858 | $212K |
| BIOABioAge Labs, Inc. | 10,300 | $180K |
| LXRXLEXICON PHARMACEUTICALS, INC. | 73,707 | $115K |
| NBPNovaBridge Biosciences | 11,178 | $27K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.